SCHEMBL31110092

SCHEMBL31110092

Cc1c(NCCCCCCCN)cccc1C(=O)Nc1cc(C)n(C)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.44
▸ LMNA P02545 1/20 0.44
▸ F10 P00742 3/20 0.39
▸ MAP3K5 Q99683 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ CNR1 P21554 4/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ HDAC3 O15379 2/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ SSTR2 P30874 1/20 0.35
▸ SSTR4 P31391 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ CASP3 P42574 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SENP8 Q96LD8 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ SENP7 Q9BQF6 1/20 0.34
▸ SENP6 Q9GZR1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25142679 0.85 ALDH1A1 (0.41) ALDH1A1LMNAMAP3K5ATMKMT2A
SCHEMBL31665564 0.84 BRD4 (0.44) —
SCHEMBL31110137 0.80 SORT1 (0.41) ALDH1A1F10ATMKMT2AHDAC3
SCHEMBL31110115 0.79 NPC1 (0.53) ALDH1A1F10KMT2AKDM4ENPC1
SCHEMBL25142787 0.79 NPC1 (0.53) ALDH1A1F10KMT2AKDM4ENPC1
SCHEMBL31110180 0.78 F10 (0.39) ALDH1A1F10KMT2AHDAC3HDAC1
SCHEMBL25143098 0.77 ALDH1A1 (0.48) ALDH1A1LMNAMAP3K5KMT2AKDM4E
SCHEMBL25142910 0.75 PIK3CA (0.47) ALDH1A1HDAC3HDAC1SSTR2SSTR4
SCHEMBL31110240 0.75 PIK3CA (0.47) ALDH1A1HDAC3HDAC1SSTR2SSTR4
SCHEMBL25142578 0.75 F10 (0.35) ALDH1A1F10KMT2AHDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250235543-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2025-07-24 — — US disclosed
CN-118451078-A Modified proteins and protein degrading agents 上海睿跃生物科技有限公司 2024-08-06 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250235543-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, TP53BP1 ALDH1A1 2239/4885LMNA 1522/4885F10 3120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback